James Investment Research Inc Haemonetics Corp Transaction History

James Investment Research Inc

  • $853 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023
SELL
$72.75 - $90.6 $12,294 - $15,311
-169 Reduced 22.3%
589 $49,000
Q4 2022

Jan 30, 2023
SELL
$73.85 - $86.14 $83,819 - $97,768
-1,135 Reduced 59.96%
758 $60,000
Q3 2022

Oct 31, 2022
BUY
$63.3 - $78.66 $119,826 - $148,903
1,893 New
1,893 $140,000

Others Institutions Holding HAE

# of Institutions
333
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email